Adrenal Gland Disorders
Adrenal disorders are a varied group of endocrine conditions, yet each leaves recognizable clinical signs on the skin. The adrenal glands make essential steroid hormones: glucocorticoids (cortisol) and mineralocorticoids (aldosterone) in the adrenal cortex, and catecholamines (epinephrine, norepinephrine) in the adrenal medulla. Any imbalance, whether adrenal insufficiency (Addison disease) or adrenal overactivity (Cushing syndrome, Conn syndrome, pheochromocytoma), acts directly on fibroblasts, pigment cells (melanocytes), keratinocytes, and the tone of the small blood vessels in the dermis.
How the skin is affected, and why:
- Chronic Adrenal Insufficiency (Addison Disease):
- The CRH–ACTH–MSH Axis and Generalized Darkening: When the adrenals make too little cortisol, the normal negative feedback is lost and the pituitary releases more of the precursor pro-opiomelanocortin (POMC). POMC is cleaved into ACTH and alpha-melanocyte-stimulating hormone (alpha-MSH). Both bind directly to the melanocortin-1 receptor (MC1R) on melanocytes in the basal layer of the epidermis, switching on the cAMP–PKA–MITF pathway and driving a surge in eumelanin production. The result is darkening of the skin all over the body, most marked in friction areas and on mucous membranes.
- Adrenal Androgen Excess (Adrenal Hyperandrogenism):
- Congenital Adrenal Hyperplasia (CAH) or Adrenocortical Tumors: Excess dehydroepiandrosterone (DHEA) and androstenedione are converted in the skin to dihydrotestosterone (DHT) by the enzyme 5-alpha-reductase. DHT binds androgen receptors (AR) in the sebaceous glands and hair follicles. This enlarges the oil glands, causing treatment-resistant acne, turns fine vellus hairs into coarse terminal hairs in androgen-dependent areas (hirsutism), and leads to male-pattern hair loss (androgenetic alopecia, AGA).
- Catecholamine Disturbance (Pheochromocytoma):
- Adrenal Medullary Tumors and Vascular Reactions: The tumor releases epinephrine and norepinephrine in bursts, abruptly constricting peripheral vessels through alpha-1 adrenergic receptors. This produces episodes of pale, net-like mottling of the skin (livedo reticularis), alternating with facial flushing as the vessels dilate in compensation.
Skin and Mucosal Signs by Type of Adrenal Disorder
| Disorder | Characteristic Skin Findings | Cellular and Molecular Mechanism |
|---|---|---|
| Primary adrenal insufficiency (Addison disease) | Diffuse bronze or gray-brown pigmentation. Most visible in palm creases, elbows, areolae, new scars, and the inner cheeks and gums. | High blood ACTH and alpha-MSH stimulate MC1R on melanocytes, increasing eumelanin synthesis. |
| Cortisol excess (Cushing syndrome) | Paper-thin, atrophic skin; deep purple stretch marks (violaceous striae wider than 1 cm); easy spontaneous bruising; monomorphic acne. | Cortisol suppresses collagen production by fibroblasts, weakens vessel walls, and dampens skin immunity. |
| Congenital adrenal hyperplasia / androgen-secreting tumors | Hirsutism on the chin, chest, and abdomen; treatment-resistant nodulocystic acne; thinning at the crown; heavy oiliness. | Excess DHEA/DHT stimulates androgen receptors (AR) in hair follicles and sebaceous glands. |
| Adrenal medullary tumor (pheochromocytoma) | Episodic facial flushing; pale skin with cold sweats; purplish net-like rash (livedo reticularis). | Sudden catecholamine surges cause marked constriction of the peripheral microcirculation. |
Telling Addison Pigmentation Apart From Other Causes of Darkening
| Addison Disease Pigmentation | Hormonal Melasma | Post-Inflammatory Hyperpigmentation (PIH) |
|---|---|---|
| Generalized; most obvious in skin folds, over joints, in new scars, and inside the mouth | Mainly on the face (cheeks, forehead, chin, bridge of the nose) | Exactly where a previous injury or inflammation occurred |
| Dark patches on the inner cheeks, gums, and tongue | Never involves mucous membranes | Does not involve mucous membranes |
| Even bronze or gray-brown color over the whole body, with no sharp borders | Brown patches with well-defined or irregular borders | Dark marks or spots that match the shape of the earlier lesion |
| Fatigue, weight loss, low blood pressure, salt craving, low blood sugar | No systemic symptoms | No systemic symptoms |
Our Approach
At Haute-Derma, we approach adrenal-related skin disease on two fronts: screening the hormonal axis and assessing the fine structure of the skin.
- Clinical Examination and Medication History:
- A detailed history of corticosteroid use in any form: topical (mixed creams, whitening creams), oral, joint injections, or asthma inhalers.
- Screening for accompanying systemic symptoms: weight loss, salt craving, and dizziness on standing (suggesting Addison disease), or high blood pressure, limb muscle wasting, and a rounded face (suggesting Cushing syndrome).
- Core Biochemical Testing: 8 a.m. serum cortisol, serum ACTH, DHEA-S, total and free testosterone, 17-OH progesterone (to screen for CAH), and electrolytes (Na+, K+).
- Imaging the Skin's Microstructure: Dermoscopy and advanced skin analysis to measure epidermal thinning, the density of dilated small vessels, transepidermal water loss (TEWL), and how deep pigment-laden cells sit in the dermis.
Treatment Options at Haute-Derma
Each plan is tailored to the patient and combines standard medical therapies:
- Barrier Repair and Pigment Reduction in Adrenal Insufficiency (Addison Disease):
- Once an endocrinologist has stabilized systemic steroid replacement (hydrocortisone/fludrocortisone), ACTH levels fall and new pigment stops forming.
- Topical treatment: Gentle tyrosinase inhibitors such as azelaic acid 15%, niacinamide 5%, and tranexamic acid 3–5% gradually fade any remaining patchy pigment.
- Sun protection: Daily broad-spectrum sunscreen that also blocks visible light (HEV) is essential to keep melanocytes from being reactivated.
- Managing Skin Changes From Androgen Excess (CAH / Adrenal Tumors):
- Controlling oil and acne: Topical retinoids (adapalene, tretinoin) combined with blue LED light therapy (415 nm) to clear C. acnes bacteria and calm the oil glands.
- Medical hair removal: Latest-generation diode laser or IPL destroys the follicles of DHT-driven excess hair without harming the surrounding tissue.
- Restoring Skin Thinned by External Corticosteroid Overuse:
- A safe, stepwise corticosteroid withdrawal, alongside lipid-barrier repair creams with an optimal ceramide ratio, madecassoside, and multi-weight hyaluronic acid.
- Red LED light (630 nm) to gently support microcirculation and fibroblast renewal.
